Mutation of superoxide dismutase elevates reactive species: Comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis

Neuroscience

Volumn 146, Issue 1, 2007, Pages 255-264

  Liu, D ^a   Bao, F ^a   Wen, J ^a   Liu, J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

cerebellar cortex; hypoglossal nucleus; motor cortex; nitric oxide; protein carbonyl content; protein bound nitrotyrosine

Indexed keywords

3 NITROTYROSINE; COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; ENZYME METABOLISM; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MOTOR CORTEX; MOUSE; MUTATIONAL ANALYSIS; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SENSORY CORTEX; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CELL COUNT; CITRULLINE; HUMANS; HYDRAZINES; MICE; MICE, TRANSGENIC; MICRODIALYSIS; MUTATION; NERVE TISSUE PROTEINS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TYROSINE;

EID: 34247485859     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.01.028     Document Type: Article

References (57)

1. Abe K., Pan L.H., Watanabe M., Kato T., and Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett 199 (1995) 152-154
2. Alexander G.M., Deitch J.S., Seeburger J.L., Del Valle L., and Heiman-Patterson T.D. Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase. J Neurochem 74 (2000) 1666-1673
3. Almer G., Vukosavic S., Romero N., and Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72 (1999) 2415-2425
4. Andrus P.K., Fleck T.J., Gurney M.E., and Hall E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71 (1998) 2041-2048
5. Bao F., DeWitt D.S., Prough D.S., and Liu D. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 71 (2003) 220-227
6. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Estevez A.G., and Beckmann J.S. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47 (2004) 263-274
7. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown Jr. R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42 (1997) 644-654
8. Beckmann J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
9. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., and White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375 (1994) 81-88
10. Beland F.A., Dooley K.L., and Casciano D.A. Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J Chromatogr 174 (1979) 177-186
11. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., and Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79 (2001) 737-746
12. Bogdanov M.B., Ramos L.E., Xu Z., and Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 71 (1998) 1321-1324
13. Bowling A.C., Schulz J.B., Brown Jr. R.H., and Beal M.F. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61 (1993) 2322-2325
14. Bruijn L.I., Beal M.F., Becher M.W., Schulz J.B., Wong P.C., Price D.L., and Cleveland D.W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci U S A 94 (1997) 7606-7611
15. Casoni F., Basso M., Massignan T., Gianazza E., Cheroni C., Salmona M., Bendotti C., and Bonetto V. Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem 280 (2005) 16295-16304
16. Chou S.M., Wang H.S., and Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 10 (1996) 249-258
17. Cookson M.R., Menzies F.M., Manning P., Eggett C.J., Figlewicz D.A., McNeil C.J., and Shaw P.J. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph Lateral Scler Other Motor Neuron Disord 3 (2002) 75-85
18. De Montigny P., Stobaugh J.F., Givens R.S., Carlson R.G., Srinivasachar K., Sternson L.A., and Higuchi T. Naphthalene-2,3-dicarboxaldehyde/cyanide ion: A rationally designed fluorogenic reagent for primary amines. Anal Chem 59 (1987) 1096-1101
19. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261 (1993) 1047-1051
20. Facchinetti F., Sasaki M., Cutting F.B., Zhai P., MacDonald J.E., Reif D., Beal M.F., Huang P.L., Dawson T.M., Gurney M.E., and Dawson V.L. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience 90 (1999) 1483-1492
21. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown Jr. R.H., and Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69 (1997) 2064-2074
22. Ferrante R.J., Shinobu L.A., Schulz J.B., Matthews R.T., Thomas C.E., Kowall N.W., Gurney M.E., and Beal M.F. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 42 (1997) 326-334
23. Fitzmaurice P.S., Shaw I.C., Kleiner H.E., Miller R.T., Monks T.J., Lau S.S., Mitchell J.D., and Lynch P.G. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19 (1996) 797-798
24. Floyd R.A., and Carney J.M. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 32 Suppl (1992) S22-S27
25. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
26. Gurney M.E., Cutting F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., and Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39 (1996) 147-157
27. Hall E.D., Andrus P.K., Oostveen J.A., Fleck T.J., and Gurney M.E. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 53 (1998) 66-77
28. Hare P.E. Subnanomole-range amino acid analysis. Methods Enzymol 47 (1977) 3-18
29. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., and Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal Biochem 251 (1997) 187-195
30. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C.A., West M., and Williamson K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82 (2002) 365-374
31. Holasek S.S., Wengenack T.M., Kandimalla K.K., Montano C., Gregor D.M., Curran G.L., and Poduslo J.F. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res 1045 (2005) 185-198
32. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20 (1997) 132-139
33. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., and Beckmann J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298 (1992) 431-437
34. Kiaei M., Bush A.I., Morrison B.M., Morrison J.H., Cherny R.A., Volitakis I., Beal M.F., and Gordon J.W. Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 24 (2004) 7945-7950
35. Leski M.L., Bao F., Wu L., Qian H., Sun D., and Liu D. Protein and DNA oxidation in spinal injury: neurofilaments: an oxidation target. Free Radic Biol Med 30 (2001) 613-624
36. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186 (1990) 464-478
37. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
38. Liu D. An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for studying excitotoxicity in spinal cord injury. Effect of NMDA and kainate. Mol Chem Neuropathol 23 (1994) 77-92
39. Liu D., Yang R., Yan X., and McAdoo D.J. Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological, and neurochemical results. J Neurochem 62 (1994) 37-44
40. Liu D., Yang J., Li L., and McAdoo D.J. Paraquat-a superoxide generator-kills neurons in the rat spinal cord. Free Radic Biol Med 18 (1995) 861-867
41. Liu D., Wen J., Liu J., and Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J 13 (1999) 2318-2328
42. Liu D., Liu J., and Wen J. Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction. Free Radic Biol Med 27 (1999) 478-482
43. Liu D., Ling X., Wen J., and Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 75 (2000) 2144-2154
44. Liu D., Li L., and Augustus L. Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: a site of the neuroprotective action of methylprednisolone. J Neurochem 77 (2001) 1036-1047
45. Liu R., Althaus J.S., Ellerbrock B.R., Becker D.A., and Gurney M.E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 44 (1998) 763-770
46. Matuszewski B.K., Givens R.S., Srinivasachar K., Carlson R.G., and Higuchi T. N-substituted 1-cyanobenz[f]isoindole: evaluation of fluorescence efficiencies of a new fluorogenic label for primary amines and amino acids. Anal Chem 59 (1987) 1102-1105
47. Ohshima H., Friesen M., Brouet I., and Bartsch H. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol 28 (1990) 647-652
48. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
49. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., and Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28 (1990) 18-25
50. Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., and Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J Neurol Sci 176 (2000) 88-94
51. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 76 (2005) 1046-1057
52. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropathol Exp Neurol 64 (2005) 649-664
53. Taskiran D., Sagduyu A., Yuceyar N., Kutay F.Z., and Pogun S. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. Int J Neurosci 101 (2000) 65-72
54. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., and Isobe C. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci Lett 260 (1999) 204-206
55. Upton-Rice M.N., Cudkowicz M.E., Mathew R.K., Reif D., and Brown Jr. R.H. Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice. Ann Neurol 45 (1999) 413-414
56. Wengenack T.M., Holasek S.S., Montano C.M., Gregor D., Curran G.L., and Poduslo J.F. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model. Brain Res 1027 (2004) 73-86
57. Xie Y., Weydt P., Howland D.S., Kliot M., and Moller T. Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. Neuroreport 15 (2004) 2513-2516